Financials
- Market Capitalization 2.49 B
- Employee 47
- Founded 1998
- CEO Helen Sabzevari
- Website www.precigen.com
- Headquarter Virginia, United States
- FIGI BBG000QL8VH9
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.05
Fiyat/satışlar oranı
135.09
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1846 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 25.61 USD | -2.48% | -0.54% | +2.28% | -16.03% | 2.52 B USD | ||
| 1851 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.82 USD | -0.51% | +3.37% | +3.70% | +17.32% | 2.51 B USD | ||
| 1862 | NKTR Nektar Therapeutics - Common Stock | 72.52 USD | -2.72% | -0.67% | +3.57% | -1.02% | 2.48 B USD | ||
| 1865 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 34.19 USD | -1.18% | +6.02% | +4.56% | +14.96% | 2.46 B USD |